Latest News in the pharma Industry
All
Skyepharma set-up for serialization and aggregation, ready for Russian market
20 Jan 2020
Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.
Read more
CURE sees delivery platform as springboard for success
20 Jan 2020
In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation
Read more.jpg)
Forté Pharma strengthens cosmetics range with oral supplement launch
20 Jan 2020
Reig Jofre's oral, anti-wrinkle, moisturizing and firming cosmetic expands Forté Pharma's beauty range.
Read more
Meet Sai Life Sciences at CPhI, Japan 2020
20 Jan 2020
Sai Life Sciences will be in Tokyo for CPhI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email [email protected]
Read more
CPhI World Wide
17 Jan 2020
CPhI Worldwide houses six zones representing each stage of the pharmaceutical supply chain - from APIs, machinery and packaging to outsourcing and biopharmaceuticals. Uniting over 45,000 visiting attendees and 2,500 international exhibitors, this ...
Read more
Wuxi to acquire Bayer final drug product manufacturing site
17 Jan 2020
First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.
Read more
Former Bosch drug packaging division renamed Syntegon
16 Jan 2020
Business to focus on intelligent and sustainable technologies.
Read more
BioMarin gets go-ahead to start gene therapy clinical trials
15 Jan 2020
BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.
Read more
GHO Capital acquires Ardena
14 Jan 2020
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma
Read more
French regulator agrees to partial resumption of Tellomak trial patient recruitment
14 Jan 2020
The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...
Read more
Biogen to acquire novel clinical-stage asset from Pfizer
14 Jan 2020
PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.
Read more
Catalent launches direct-to-patient clinical supply services
14 Jan 2020
Multiple options provide increased flexibility for sponsors.
Read more